Ph.D. Pathways

Jennifer LeLaurin, Ph.D., dedicates her career to improving how health care systems support patients and caregivers through tobacco cessation and cancer care research.

Bayli DiVita Dean, Ph.D. ’20, founded a science communications consulting company.

Naomi Parker studies how to make cancer clinical trials more accessible.

Gabriela Hery’s research focuses on comparing gene expression profiles and lipid distributions in canine and human osteosarcoma.

Miranda Reid's current work focuses on the sustainability of tobacco treatment programs, particularly those funded by the NCI.

Arinola Lampejo's research explores vessel plasticity in the tumor microenvironment.

Chayil Lattimore's work involves investigating the impact of differential miRNA expression on racial disparities in advanced-stage laryngeal cancer.

Andrew Maxim plans to continue his cancer research in virtual environments and focus on HPV vaccine efforts.  

Daniel Stribling hopes to be part of applying the rapidly advancing fields of AI to genomics and medicine.